Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

被引：0
|
作者：
Megan E. McNally
Antonio Martinez
Hooman Khabiri
Gregory Guy
Anthony J. Michaels
James Hanje
Robert Kirkpatrick
Mark Bloomston
Carl R. Schmidt
机构：
[1] The Ohio State University Medical Center,Department of Surgery
[2] The Ohio State University College of Medicine,Department of Radiology
[3] The Ohio State University Medical Center,Department of Medicine, Division of Gastroenterology
[4] The Ohio State University Medical Center,undefined
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Tace; Portal Vein Thrombosis; Radiographic Response; Tace Procedure; Ioxaglate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：923 / 928
页数：5
相关论文
共 50 条
  • [1] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    McNally, Megan E.
    Martinez, Antonio
    Khabiri, Hooman
    Guy, Gregory
    Michaels, Anthony J.
    Hanje, James
    Kirkpatrick, Robert
    Bloomston, Mark
    Schmidt, Carl R.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 923 - 928
  • [2] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma (HCC) undergoing Transarterial Chemoembolization (TACE)
    McNally, M. E.
    Martinez, A.
    Malhotra, L.
    Bloomston, M.
    Schmidt, C. R.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S33 - S33
  • [3] Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Rebonato, A.
    Graziosi, L.
    Maiettini, D.
    Marino, E.
    De Angelis, V.
    Brunese, L.
    Mosca, S.
    Metro, G.
    Rossi, M.
    Orgera, G.
    Scialpi, M.
    Donini, A.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [4] UNRESECTABLE HEPATOCELLULAR CARCINOMA: PREDICTION OF OUTCOME AFTER TRANSARTERIAL CHEMOEMBOLIZATION
    Cabibbo, Giuseppe
    Di Marco, Vito
    Barbara, Marco
    Genco, Chiara
    Brancatelli, Giuseppe
    Romano, Piero
    Sandonato, Luigi
    Craxi, Antonio
    Camma, Calogero
    HEPATOLOGY, 2010, 52 (04) : 1160A - 1160A
  • [5] Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Jie Wu
    Lei Song
    Dan-Yi Zhao
    Bing Guo
    Jing Liu
    World Journal of Gastroenterology, 2014, (31) : 10960 - 10968
  • [6] Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Wu, Jie
    Song, Lei
    Zhao, Dan-Yi
    Guo, Bing
    Liu, Jing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10960 - 10968
  • [7] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Burroughs, Andrew
    Samonakis, Dirnitrios
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 78 - 79
  • [8] Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma
    Wang, Peng
    Sheng, Lili
    Wang, Guoxiang
    Wang, Heping
    Huang, Xinyu
    Yan, Xiaoxing
    Yang, Xiaohua
    Pei, Renguang
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 203 - 206
  • [9] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Andrew Burroughs
    Dimitrios Samonakis
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 78 - 79
  • [10] Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
    Tan, Bin-Bin
    Fu, Ying
    Shao, Ming-Hua
    Chen, Hai-Lei
    Liu, Ping
    Fan, Chao
    Zhang, Hui
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (09):
12345